So, lorlatinib is this fancy new medicine made to help people whose lung cancer, which is ALK-positive, has kept on growing even after taking other ALK drugs. It acts by zeroing in on these bad guys, the ALK and ROS1 kinases, which are like the tumors’ favorite energy source, and then just shutting that source down. It’s available in two doses: a smaller one of 25 mg and a bigger one of 100 mg, both in those easy-to-swallow tablets with the shiny coating.
The thing to do is pop a 100-milligram pill everyday, either when you’re hungry or right after you’ve chowed down. You’ll find these pills packed in bottles, with 30 pills in each bottle.
